Filter
440
Filtered Results: 440
Text search:
National
Institute
for
Viral
Disease
Control
and
Prevention,
China
Featured
Recommendations
61
New Publications
64
Language
Document type
No document type
157
Guidelines
129
Studies & Reports
82
Manuals
31
Strategic & Response Plan
18
Fact sheets
11
Situation Updates
5
Training Material
4
Resource Platforms
2
Infographics
1
Countries / Regions
Global
19
India
15
South Africa
13
Brazil
10
Western and Central Europe
10
Latin America and the Carribbean
8
Africa
8
Germany
7
Russia
7
Vietnam
6
Kenya
5
Mozambique
5
Peru
4
Colombia
4
Ecuador
4
Bolivia
4
Angola
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Asia
4
Spain
4
Guinea-Bissau
3
Uganda
3
Syria
3
China
3
Ukraine
3
Myanmar / Burma
3
East and Southern Africa
3
Eastern Europe
3
Portugal
3
Guinea
2
Ethiopia
2
Pakistan
2
Bangladesh
2
Papua New Guinea
2
Namibia
2
Venezuela
2
Laos
2
France
2
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
Ghana
1
Zimbabwe
1
South Sudan
1
Jordan
1
Turkey
1
Tanzania
1
Cambodia
1
Thailand
1
Malawi
1
Sudan
1
Central African Republic
1
Argentina
1
North Macedonia
1
Honduras
1
Botswana
1
El Salvador
1
Mexico
1
Chile
1
Yemen
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Albania
1
North America
1
Mauritius
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
116
Clinical Guidelines
62
Public Health
18
Women & Child Health
9
Key Resources
8
Pharmacy & Technologies
7
Capacity Building
2
Toolboxes
COVID-19
142
HIV
77
Rapid Response
28
TB
19
AMR
17
Mental Health
15
Planetary Health
15
Ebola
10
Global Health Education
9
NCDs
8
Refugee
7
NTDs
7
Specific Hazards
5
Disability
4
Pharmacy
4
Polio
3
Conflict
2
Natural Hazards
2
Zika
2
Health Financing Toolbox
2
Cholera
1
Health Financing
1
Supplement Article
WHO Guidelines for HIV PEP • CID 2015:60 (Suppl 3), S161 - S164
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods ... economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive focus during the first phase of the crisis, governments are now trying to strike a delicate balance between preventing further economic damage by reopening parts of their economies, while managing the obvious health risks of doing so.
In the international mobility and migration arenas—policy areas enormously affected by the health and economic effects of the pandemic—this reflection considers both how these fields have fared thus far and the challenges that lay ahead
Since the start of the pandemic, the region has been hit by multiple natural and biological disasters. At the same time, climate change has continued to warm the world, exacerbating the impacts of many of these disasters. The *Asia-Pacific Disaster ...
A all for global Action. The Oral Health Atlas. Second edition
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater ... exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infections caused by AMR organisms. With drugs not listed on the essential drugs list (EDL), problems of increased morbidity, costs of extended hospitalisation and mortality are extremely serious. The problem of susceptibility to and spread of infections caused by multidrug-resistant (MDR) infectious agents is fuelled by factors such as limited access to clean water and sanitation to ensure personal hygiene, malnutrition, and the HIV/TB epidemic.
Practical Guideline for collaborative interventions
Background paper 10
The Independent Panel for Pandemic Preparedness and Response
May 2021
Practical Guidance for collaborative interventions
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal o...
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
This Commission report aims to contribute to a new era of multilateral cooperation based on strong UN institutions to reduce the dangers of COVID-19, forestall the next pandemic, and enable the world to achieve the agreed goals of sustainable develo...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment ...
Practical Guidance for collaborative interventions
Third Stocktaking Report, 2008
Unite for Children, Unite against AIDS
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- ... middle-income countries (LMICs). In the absence of implementing the known evidence-based, cost-effective interventions, the number of deaths per year is projected to reach approximately 416 000 globally in 2035. It was estimated in 2020 that 32% of incident cervical cancer cases and 34% of cervical cancer deaths in the world occurred in the 11 Member States of the WHO South-East Asia (SEA) Region. In 2020, 190 874 new cases and 116 015 deaths were estimated due to cervical cancer, which is the third commonest cancer in the Region
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- ... middle-income countries, since preparing and storing it require personnel and laboratory infrastructure that are often lacking. An alternative specimen type is dried blood spots (DBS), which can be made without special laboratory processing. DBS are more easily transported than plasma because they can be shipped at ambient temperature as non-hazardous materials using regular mail or courier services.
3rd edition
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an ov...
